Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials

Seyed Samad Hosseini, Saeed Khalili, Behzad Baradaran, Negar Bidar, Mohammad-Ali Shahbazi, Jafar Mosafer, Mahmoud Hashemzaei, Ahad Mokhtarzadeh, Michael R. Hamblin

Research output: Contribution to journalReview Articlepeer-review

Original languageEnglish
JournalInternational Journal of Biological Macromolecules
Volume167
Pages (from-to)1030-1047
Number of pages18
ISSN0141-8130
DOIs
Publication statusPublished - 15 Jan 2021
MoE publication typeA2 Review article in a scientific journal

Fields of Science

  • Bispecific antibodies
  • Solid tumor
  • Immunotherapy
  • Bispecific T cell engagers
  • Clinical trials
  • GROWTH-FACTOR RECEPTOR
  • SINGLE-CHAIN ANTIBODY
  • T-CELL-ENGAGER
  • PHASE-II TRIAL
  • CANCER-THERAPY
  • CARCINOEMBRYONIC ANTIGEN
  • MALIGNANT ASCITES
  • LOCK METHOD
  • X ANTI-CD3
  • NK CELLS
  • 3111 Biomedicine
  • 3122 Cancers
  • 116 Chemical sciences
  • 1182 Biochemistry, cell and molecular biology
  • 317 Pharmacy

Cite this